Stocks and Investing
Stocks and Investing
Thu, July 25, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Caitlin Cronin Maintained (TELA) at Strong Buy and Held Target at $14 on, Jul 25th, 2024
Caitlin Cronin of Canaccord Genuity, Maintained "TELA Bio, Inc." (TELA) at Strong Buy and Held Target at $14 on, Jul 25th, 2024.
Caitlin has made no other calls on TELA in the last 4 months.
There is 1 other peer that has a rating on TELA. Out of the 1 peers that are also analyzing TELA, 0 agree with Caitlin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Caitlin
- Matt O'Brien of "Piper Sandler" Reiterated at Buy with Decreased Target to $10 on, Friday, May 10th, 2024
Contributing Sources